Publication | Closed Access

Development of a lipoplex-type mRNA carrier composed of an ionizable lipid with a vitamin E scaffold and the KALA peptide for use as an ex vivo dendritic cell-based cancer vaccine

VaccinationVaccine DevelopmentVaccine ResearchMedicineImmunologyTherapeutic VaccineVitamin E ScaffoldCancer VaccinesVaccine DesignImmunotherapyLipoplex-type Mrna CarrierCell BiologyKala Peptide